These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Clinical experience with tiapride in the treatment of extrapyramidal syndromes].
    Author: Csanda E, Fornadi F.
    Journal: Sem Hop; 1982 Dec 09; 58(45):2647-50. PubMed ID: 6297061.
    Abstract:
    Tiapride was given at an average dosage of 300-900 mg per day, intramuscularly for the first three days, then by oral route, to 62 patients with abnormal movements of various types. The best responses were recorded in chorea and bucco-lingua-facial dyskinesia as well as in dyskinetic movements induced by levo-dopa in Parkinson patients. Clinical and biological tolerance of tiapride was excellent, with only one case of drowsiness and two cases of galactorrhea.
    [Abstract] [Full Text] [Related] [New Search]